Bipin Mistry

662 total citations
24 papers, 469 citations indexed

About

Bipin Mistry is a scholar working on Oncology, Analytical Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bipin Mistry has authored 24 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Analytical Chemistry and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bipin Mistry's work include Analytical Methods in Pharmaceuticals (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Bipin Mistry is often cited by papers focused on Analytical Methods in Pharmaceuticals (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Bipin Mistry collaborates with scholars based in United States, United Kingdom and Australia. Bipin Mistry's co-authors include James Leslie, Natalie D. Eddington, Robert S. Kaplan, Feryal Erhun, Terry Platchek, Donna S. Cox, V.G. Narayanan, Aaron H. Burstein, Jean Claude Mugunga and Arnold Milstein and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Bipin Mistry

24 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bipin Mistry United States	13	99	68	66	61	57	24	469
Emmanuel Saltiel United States	8	55 0.6×	49 0.7×	28 0.4×	59 1.0×	48 0.8×	18	645
Hanna Kortejärvi Finland	12	66 0.7×	76 1.1×	102 1.5×	18 0.3×	16 0.3×	15	465
Yang Tian China	16	201 2.0×	31 0.5×	20 0.3×	47 0.8×	74 1.3×	40	654
Joseph F. Gallelli United States	16	146 1.5×	105 1.5×	38 0.6×	19 0.3×	15 0.3×	49	639
Esther V. Uijtendaal Netherlands	10	131 1.3×	13 0.2×	49 0.7×	31 0.5×	8 0.1×	18	689
Xiaomei Gu United States	12	77 0.8×	154 2.3×	16 0.2×	106 1.7×	26 0.5×	31	685
Tai Ning Lam Hong Kong	12	101 1.0×	43 0.6×	25 0.4×	6 0.1×	17 0.3×	29	476
J Cabeza Barrera Spain	16	260 2.6×	131 1.9×	23 0.3×	24 0.4×	9 0.2×	60	657
Ljiljana Tasić Serbia	14	41 0.4×	7 0.1×	27 0.4×	54 0.9×	34 0.6×	56	429
Andrew P. Lea Portugal	10	127 1.3×	74 1.1×	39 0.6×	39 0.6×	5 0.1×	11	676

Countries citing papers authored by Bipin Mistry

Since Specialization

Citations

This map shows the geographic impact of Bipin Mistry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bipin Mistry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bipin Mistry more than expected).

Fields of papers citing papers by Bipin Mistry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bipin Mistry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bipin Mistry. The network helps show where Bipin Mistry may publish in the future.

Co-authorship network of co-authors of Bipin Mistry

This figure shows the co-authorship network connecting the top 25 collaborators of Bipin Mistry. A scholar is included among the top collaborators of Bipin Mistry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bipin Mistry. Bipin Mistry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Ziheng, et al.. (2024). Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension. CPT Pharmacometrics & Systems Pharmacology. 13(8). 1380–1393. 2 indexed citations

Plummer, Ruth, Nicola Cresti, Yvette Drew, et al.. (2020). First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor. British Journal of Cancer. 123(4). 525–533. 57 indexed citations

Jamei, Masoud, et al.. (2019). Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 141. 191–209. 8 indexed citations

Martinez, Marilyn N., Bipin Mistry, Kimberley A. Lentz, et al.. (2017). Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs. The AAPS Journal. 19(3). 712–726. 4 indexed citations

Mather, Richard C., et al.. (2017). Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model. The Journal of Arthroplasty. 32(11). 3268–3273.e4. 17 indexed citations

Mistry, Bipin, Nikunjkumar Patel, Masoud Jamei, Amin Rostami‐Hodjegan, & Marilyn N. Martinez. (2016). Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process. The AAPS Journal. 18(5). 1144–1158. 15 indexed citations

McBain, Ryan K., Gregory Jérôme, Bipin Mistry, et al.. (2016). Rethinking the cost of healthcare in low-resource settings: the value of time-driven activity-based costing. BMJ Global Health. 1(3). e000134–e000134. 44 indexed citations

Mandigo, Morgan, Kathleen O’Neill, Bipin Mistry, et al.. (2015). A time-driven activity-based costing model to improve health-care resource use in Mirebalais, Haiti. The Lancet. 385. S22–S22. 24 indexed citations

Wozniak, Krystyna M., James J. Vornov, Bipin Mistry, et al.. (2015). Gastrointestinal delivery of propofol from fospropofol: its bioavailability and activity in rodents and human volunteers. Journal of Translational Medicine. 13(1). 170–170. 12 indexed citations

10.

Shah, Neel, et al.. (2015). A Cost Analysis of Hospitalization for Vaginal and Cesarean Deliveries [282]. Obstetrics and Gynecology. 125(Supplement 1). 91S–91S. 4 indexed citations

11.

Erhun, Feryal, Bipin Mistry, Terry Platchek, et al.. (2015). Time-driven activity-based costing of multivessel coronary artery bypass grafting across national boundaries to identify improvement opportunities: study protocol. BMJ Open. 5(8). e008765–e008765. 33 indexed citations

12.

Ferraris, Dana, Bridget Duvall, Greg Delahanty, et al.. (2014). Design, Synthesis, and Pharmacological Evaluation of Fluorinated Tetrahydrouridine Derivatives as Inhibitors of Cytidine Deaminase. Journal of Medicinal Chemistry. 57(6). 2582–2588. 45 indexed citations

13.

Mita, Alain C., Monica Mita, John Sarantopoulos, et al.. (2011). Abstract B185: Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the poly(ADP-ribose) polymerase (PARP) inhibitor E7016 in combination with temozolomide (TMZ) in patients with advanced solid tumors.. Molecular Cancer Therapeutics. 10(11_Supplement). B185–B185. 5 indexed citations

14.

Mistry, Bipin, Mark M. Jones, Peter Kubiak, et al.. (2011). A Phase 1 Study to Assess the Absolute Bioavailability and Safety of An Oral Solution of Decitabine In Subjects with Myelodysplastic Syndromes (MDS),. Blood. 118(21). 3801–3801. 18 indexed citations

15.

Mistry, Bipin, Yuki Nishioka, Jean Fan, & David Verbel. (2011). Abstract A193: Assessment of effect of low- and high-fat diet on E7050 pharmacokinetics and characterization of E7050 pharmacokinetics after 100 mg, 200 mg, and 400 mg single oral doses in healthy subjects.. Molecular Cancer Therapeutics. 10(11_Supplement). A193–A193. 2 indexed citations

16.

Shah, Ajit, J. Fechner, Michel Struys, & Bipin Mistry. (2007). Single-Dose Crossover Pharmacokinetic/Pharmacodynamic Study of Fospropofol vs Propofol in Healthy Volunteers. The American Journal of Gastroenterology. 102. S455–S456. 2 indexed citations

17.

Bacon, B., et al.. (2001). Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. The American Journal of Gastroenterology. 96(8). 2468–2472. 27 indexed citations

18.

Mistry, Bipin, James Leslie, & Natalie D. Eddington. (2001). Enantiomeric separation of metoprolol and α-hydroxymetoprolol by liquid chromatography and fluorescence detection using a chiral stationary phase. Journal of Chromatography B Biomedical Sciences and Applications. 758(2). 153–161. 36 indexed citations

19.

Burstein, Aaron H., Donna S. Cox, Bipin Mistry, & Natalie D. Eddington. (1999). Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats. Epilepsy Research. 34(2-3). 129–133. 23 indexed citations

20.

Mistry, Bipin, et al.. (1998). A sensitive assay of metoprolol and its major metabolite α-hydroxy metoprolol in human plasma and determination of dextromethorphan and its metabolite dextrorphan in urine with high performance liquid chromatography and fluorometric detection. Journal of Pharmaceutical and Biomedical Analysis. 16(6). 1041–1049. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact